Stocks · Korea
284620
KOSDAQ
Kainos Medicine
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+0.00%
1M+0.00%
3M+0.00%
6M+0.00%
1Y+0.00%
YTD+0.00%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 1억 | -162억 | -159억 | -12,425.1% |
| 2023 | 3억 | -168억 | -152억 | -6,289.1% |
| 2024 | 6억 | -123억 | -122억 | -2,088.2% |
| 2025 | 12억 | -64억 | -78억 | -549.6% |
| Quarterly | ||||
| 2024 4Q | 71,325,969원 | -42억 | -42억 | -5,858.3% |
| 2025 1Q | 4억 | -17억 | -22억 | -458.1% |
| 2025 2Q | 2억 | -9억 | -19억 | -535.4% |
| 2025 3Q | 3억 | -15억 | -18억 | -467.3% |
| 2025 4Q | 3억 | -23억 | -19억 | -755.8% |
| 2026 1Q | 4억 | -10억 | -13억 | -273.2% |
Company
Address: 경기도 성남시 분당구 대왕판교로 660 유스페이스1 A동 1210호 일부
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.